S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
AMZN   2,009.29 (-4.14%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
AMZN   2,009.29 (-4.14%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
AMZN   2,009.29 (-4.14%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
AMZN   2,009.29 (-4.14%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
Log in

OTCMKTS:NMRD - Nemaura Medical Stock Price, Forecast & News

$3.29
+0.15 (+4.78 %)
(As of 02/24/2020 04:00 PM ET)
Add
Today's Range
$3.28
Now: $3.29
$3.35
50-Day Range
$2.85
MA: $3.32
$3.68
52-Week Range
$2.50
Now: $3.29
$14.80
Volume4,838 shs
Average Volume4,868 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Nemaura Medical, Inc. is a holding company. The Company owns a diagnostic medical device company specializing in discovering, developing and commercializing specialty medical devices. The Company's focus is on the development of a continuous glucose monitoring (CGM) device, which consists of a disposable patch containing a sensor, and a non-disposable miniature electronic watch with a re-chargeable power source. CGM through a non-invasive patch can enable early detection of subtle changes in blood glucose levels. The Company, through its operating subsidiaries, performs medical device research and manufacturing of a CGM, named sugarBEAT. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes, and may also be used to screen pre-diabetic patients. The sugarBEAT device extracts analytes, such as glucose, to the surface of the skin in a non-invasive manner where it is measured using sensors and interpreted using an algorithm.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolOTCMKTS:NMRD
Previous SymbolNASDAQ:NMRD
CUSIPN/A
Phone+44-1509-222912

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive NMRD News and Ratings via Email

Sign-up to receive the latest news and ratings for NMRD and its competitors with MarketBeat's FREE daily newsletter.


Nemaura Medical (OTCMKTS:NMRD) Frequently Asked Questions

What is Nemaura Medical's stock symbol?

Nemaura Medical trades on the OTCMKTS under the ticker symbol "NMRD."

How were Nemaura Medical's earnings last quarter?

Nemaura Medical Inc (OTCMKTS:NMRD) posted its quarterly earnings results on Monday, February, 10th. The company reported ($0.02) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.10) by $0.08. View Nemaura Medical's Earnings History.

Has Nemaura Medical been receiving favorable news coverage?

Press coverage about NMRD stock has trended very negative this week, InfoTrie reports. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Nemaura Medical earned a news sentiment score of -3.0 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Nemaura Medical.

What other stocks do shareholders of Nemaura Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nemaura Medical investors own include Gilead Sciences (GILD), Novavax (NVAX), VBI Vaccines (VBIV), AbbVie (ABBV), Actinium Pharmaceuticals (ATNM), Matinas BioPharma (MTNB), Allena Pharmaceuticals (ALNA), Biocept (BIOC), BIOLINERX LTD/S (BLRX) and Corbus Pharmaceuticals (CRBP).

Who are Nemaura Medical's key executives?

Nemaura Medical's management team includes the folowing people:
  • Dewan Fazlul Hoque Chowdhury, Chairman of the Board, President, Chief Executive Officer (Age 42)
  • Iain Anderson, Chief Financial Officer
  • Karrar Khan, Director of Product Development (Age 79)
  • David Scott, Director of Commercial Development and Licensing (Age 64)
  • Richard Toon, Business and Technical Development Manager (Age 45)
  • Bashir Timol, Director (Age 40)
  • Timothy Johnson, Independent Director
  • Thomas Moore, Independent Director
  • Salim Natha, Independent Director

How do I buy shares of Nemaura Medical?

Shares of NMRD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Nemaura Medical's stock price today?

One share of NMRD stock can currently be purchased for approximately $3.29.

What is Nemaura Medical's official website?

The official website for Nemaura Medical is http://www.nemauramedical.com/.

How can I contact Nemaura Medical?

Nemaura Medical's mailing address is Advanced Technology Innovation Centre Loughborough Univ Science & Enterprise, LOUGHBOROUGH, LE11 3QF, United Kingdom. The company can be reached via phone at +44-1509-222912.


MarketBeat Community Rating for Nemaura Medical (OTCMKTS NMRD)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  48 (Vote Outperform)
Underperform Votes:  42 (Vote Underperform)
Total Votes:  90
MarketBeat's community ratings are surveys of what our community members think about Nemaura Medical and other stocks. Vote "Outperform" if you believe NMRD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NMRD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel